Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.
Click here for original story, Host-cell factors involved in COVID-19 infections may augur improved treatments
Source: Phys.org